Focuses on gene therapy and neurodegeneration, leveraging comparative veterinary models to accelerate translation to human studies. Emphasis on CNS‑targeted viral delivery, multimodal biomarkers (neuroimaging and CSF), and cross‑species genomics, with collaborations in oncology and infectious disease.